S-3/A 1 ds3a.htm PRE-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3 FOR GLOBAEL EPOINT, INC. Pre-Effective Amendment No. 1 to Form S-3 for Globael ePoint, Inc.
Table of Contents

As filed with the Securities and Exchange Commission on December 2, 2005

 

Registration No. 333-129938

 


 

U.S. SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 


 

PRE-EFFECTIVE AMENDMENT NO. 1 TO

FORM S-3

REGISTRATION STATEMENT

UNDER THE SECURITIES ACT OF 1933

 


 

GLOBAL EPOINT, INC.

(Exact name of registrant as specified in its charter)

 

Nevada

(State or other jurisdiction

of incorporation or organization)

  

33-0423037

(I.R.S. Employer

Identification No.)

 


 

339 South Cheryl Lane

City of Industry, California 91789

(909) 869-1688

(Address, including zip code, and telephone number, including

area code, of registrant’s principal executive offices)

 

Toresa Lou, Chief Executive Officer

Global ePoint, Inc.

339 South Cheryl Lane

City of Industry, California 91789

(909) 869-1688

(Name, address, including zip code, and telephone

number, including area code, of agent for service)

 


 

Copy to:

Daniel K. Donahue, Esq.

Preston Gates & Ellis LLP

1900 Main Street, Suite 600

Irvine, California 92614-7319

(949) 253-0900

 


 

Approximate date of commencement of proposed sale to the public:

From time to time after the effective date of this Registration Statement

 

If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box: ¨

 

If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box: x

 

If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering: ¨

 

If this form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering: ¨

 

If delivery of the prospectus is expected to be made pursuant to Rule 434, please check the following box: ¨

 

CALCULATION OF REGISTRATION FEE

 

Title of each class of securities
to be registered
   Amount to be
registered(1)
   Proposed maximum
offering price
per share
    Proposed maximum
aggregate
offering price
     Amount of
registration
fee
 

Common Stock, $.03 par value per share

   4,326,936 shares    $ 2.69 (2)   $ 11,639,457 (2)    $ 1,369.96 (2)(3)

Common Stock, $.03 par value per share

   123,558 shares    $ 3.41 (4)   $ 421,333 (4)    $ 49.60 (4)
(1) In addition, pursuant to Rule 416 under the Securities Act of 1933, this Registration Statement includes an indeterminate number of additional shares as may be issuable as a result of stock splits or stock dividends which occur during this continuous offering.

 

(2) Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457 under the Securities Act of 1933 based upon the average of the high and low prices of the registrant’s common stock on November 21, 2005 on the NASDAQ stock market.

 

(3) Previously paid.

 

(4) Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457 under the Securities Act of 1933 based upon the average of the high and low prices of the registrant’s common stock on December 1, 2005.

 

The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933 or until the registration statement shall become effective on such date as the Commission, acting pursuant to Section 8(a), may determine.


Table of Contents

The information in this prospectus is not complete and may be changed. We may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and is not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.

 

SUBJECT TO COMPLETION, DATED DECEMBER 2, 2005

 

PROSPECTUS

 

GLOBAL EPOINT, INC.

 

4,450,494 SHARES

OF COMMON STOCK

 


 

This prospectus relates to shares of common stock of Global ePoint, Inc. that may be offered for sale for the account of the selling stockholders identified in this prospectus. The selling stockholders may offer and sell from time to time up to 4,450,494 shares of our common stock, which amount includes 3,008,183 shares to be issued to the selling stockholders only if and when they exercise warrants held by them.

 

The selling stockholders may sell all or any portion of their shares of common stock in one or more transactions on the NASDAQ stock market or in private, negotiated transactions. Each selling stockholder will determine the prices at which it sells its shares. Although we will incur expenses in connection with the registration of the common stock, we will not receive any of the proceeds from the sale of the shares of common stock by the selling stockholders. We will receive gross proceeds of up to $15,569,316 from the exercise of the warrants, if and when they are exercised.

 

Our common stock is listed on the NASDAQ stock market and traded under the symbol “GEPT.” On November 30, 2005, the closing price of the common stock on the NASDAQ stock market was $3.36 per share.

 

We may amend or supplement this prospectus from time to time by filing amendments or supplements as required. You should read this entire prospectus and any amendments or supplements carefully before you make your investment decision.

 


 

The shares of common stock offered or sold under this prospectus involve a high degree of risk. See “ Risk Factors” beginning at Page 5.

 


 

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the accuracy or adequacy of this prospectus. Any representation to the contrary is a criminal offense.

 


 

The date of this prospectus is December     , 2005


Table of Contents

TABLE OF CONTENTS

 

PROSPECTUS SUMMARY

   4

RISK FACTORS

   5

USE OF PROCEEDS

   9

SELLING STOCKHOLDERS

   10

PLAN OF DISTRIBUTION

   13

DESCRIPTION OF SECURITIES TO BE REGISTERED

   15

LEGAL MATTERS

   17

EXPERTS

   17

AVAILABLE INFORMATION

   17

INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE

   17

 

We have not authorized any person to give you any supplemental information or to make any representations for us. You should not rely upon any information about our company that is not contained in this prospectus or in one of our public reports filed with the Securities and Exchange Commission (“SEC”) and incorporated into this prospectus. Information contained in this prospectus or in our public reports may become stale. You should not assume that the information contained in this prospectus, any prospectus supplement or the documents incorporated by reference are accurate as of any date other than their respective dates, regardless of the time of delivery of this prospectus or of any sale of the shares. Our business, financial condition, results of operations and prospects may have changed since those dates. The selling stockholders are offering to sell, and seeking offers to buy, shares of our common stock only in jurisdictions where offers and sales are permitted.

 

In this prospectus, “Global ePoint,” the “company,” “we,” “us,” and “our” refer to Global ePoint, Inc., a Nevada corporation and its subsidiaries.

 

2


Table of Contents

ABOUT FORWARD-LOOKING STATEMENTS

 

This prospectus contains and incorporates by reference forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 which reflect our current view (as of the date such forward-looking statement is made) with respect to future events, prospects, projections or financial performance. Words such as “believes,” “expects,” “may,” “will,” “would,” “should,” “could,” “seek,” “intends,” “plans,” “potential,” “continue,” “estimates,” “anticipates,” “predicts,” and similar expressions or variations or negatives of such words are intended to identify forward-looking statements, but are not the exclusive means of identifying forward-looking statements in this prospectus. Additionally, statements concerning future matters such as the development of new products, enhancements or technologies, sales levels, expense levels and other statements regarding matters that are not historical are forward-looking statements. Although forward-looking statements in this prospectus reflect the current good faith judgment of our management, such statements are based on facts and factors currently known by us. Consequently, forward-looking statements involve inherent risks and uncertainties and actual results and outcomes may differ materially and adversely from the results and outcomes discussed in or anticipated by the forward-looking statements. A number of important factors could cause our actual results to differ materially and adversely from those in the forward-looking statements. We urge you to consider the risks and uncertainties discussed elsewhere in this prospectus under the caption “Risk Factors” and in the other documents we file with the SEC in evaluating our forward-looking statements. We have no plans, and undertake no obligation, to revise or update our forward-looking statements to reflect any event or circumstance that may arise after the date of this prospectus. We caution readers not to place undue reliance upon any forward-looking statements.

 

3


Table of Contents

PROSPECTUS SUMMARY

 

This summary highlights information contained elsewhere in this prospectus. It is not complete and may not contain all of the information that you should consider before investing in the common stock. You should read this entire prospectus carefully.

 

The Company

 

Global ePoint, Inc. and its subsidiaries is a provider of computers, computing solutions, and digital video surveillance products. Our business is operated from three divisions: our contract manufacturing division, our digital technology division, and our aviation division.

 

Our contract manufacturing division manufactures customized computing systems for the industrial, business and consumer markets, with the capability of specialized, custom-manufacture of other electronic products and systems. In addition to custom manufacturing, the division also sources and distributes electronic components and parts.

 

Our digital technology division focuses on designing, marketing and selling digital video products, primarily for commercial, industrial, homeland security, and law enforcement surveillance systems. These systems can transmit video, audio and data files using many of the existing wireless networks. This division is in its early stages of growth, and continues to concentrate on developing and acquiring new products and technologies and has not yet produced significant revenues.

 

Our aviation division, known as Global Airworks, is an aviation service company specializing in commercial aircraft surveillance systems and interior modification. The division’s current products include cockpit door surveillance systems which uses digital video technology to allow the pilot to view activity behind the secured cockpit door from the cockpit. The division has also developed an electronic flight bag that uses digital technology to store and retrieve flight manuals and procedures. The division also provides wire and harness solutions for various electrical applications within an aircraft.

 

Our executive offices are located at 339 S. Cheryl Lane, City of Industry, CA 91789, telephone (909) 869-1688.

 

The Offering

 

This offering relates to the offer and sale of our common shares by the selling stockholders identified in this prospectus. The selling stockholders will determine when they will sell their shares, and in all cases will sell their shares at the current market price or at negotiated prices at the time of the sale. Although we have agreed to pay the expenses related to the registration of the shares being offered, we will not receive any proceeds from the sale of the shares by the selling stockholders.

 

4


Table of Contents

RISK FACTORS

 

You should carefully consider the following risk factors before investing in our common stock. Our business and results of operations could be seriously harmed by any of the following risks. The trading price of our common stock could decline due to any of these risks, and you may lose part or all of your investment.

 

We require additional funding in the future to continue to operate our business.

 

As of September 30, 2005, we had net working capital totaling $156,000. Our working capital has continued to deteriorate due to ongoing losses. However, in November 2005, we completed a private placement sale of Series D preferred stock and warrants for the net proceeds of approximately $5.7 million. We believe that we will require an additional $3 million of working capital in addition to the proceeds of the Series D financing and cash generated by operations to meet our near term working capital needs, capital expenditures, and commitments over the next 12 months. If we are to be successful in acquiring Astrophysics, we will require an additional $15 million of funding. We will endeavor to raise the additional required funds through various financing sources, including the sale of our equity and debt securities and the procurement of commercial debt financing. However, there can be no guarantees that such funds will be available on commercially reasonable terms, if at all. If such financing is not available on satisfactory terms, we may be unable to expand or continue our business as desired and operating results may be adversely affected. Debt financing will increase expenses and must be repaid regardless of operating results. Equity financing could result in dilution to existing stockholders.

 

In addition, any financing arrangement may have potentially adverse effects on us or our stockholders. Debt financing (if available and undertaken) may involve restrictions limiting our operating flexibility. Moreover, if we issue equity securities to raise additional funds, the following results may occur:

 

    the percentage ownership of our existing stockholders will be reduced;

 

    our stockholders may experience additional dilution in net book value per share; or

 

    the new equity securities may have rights, preferences or privileges senior to those of the holders of our common stock.

 

We rely on related parties for a substantial portion of our revenues and as the primary source for our component and subsystem purchases. The loss of business from any of these related parties would adversely affect our business. In the ordinary course of our business, we purchase from, sell products to and perform contract manufacturing services for a number of related parties that are owned or otherwise controlled by Mr. John Pan, our chief financial officer, chairman, and largest stockholder. During 2004 and the first nine months of 2005 we purchased approximately $5.7 and $8.7 million, respectively, worth of products from these related parties. This represents 35% and 51% of our overall cost of goods for the year ended December 31, 2004 and the nine months ended September 30, 2005, respectively. In addition, during 2004 and the first nine months of 2005, we sold approximately $7.8 and $9.5 million, respectively, worth of products and contract manufacturing services to these related parties. This represents 37% and 47% of our overall sales for the year ended December 31, 2004 and the nine months ended September 30, 2005, respectively. We believe that these related party relationships provide access to attractively priced components and products and an additional and substantial amount of sales revenues. However, there are no agreements, written or otherwise, between Global ePoint and these related parties obligating such parties to transact business with us in the future. As a result, these types of

 

5


Table of Contents

related party transactions could cease at any time. If our transactions with these related parties cease, our business would be adversely affected.

 

Our current revenues and purchases are dependent on a limited number of customers and suppliers, most of which are related parties. For the nine months ended September 30, 2005 and 2004, three customers accounted for 66% and 61%, respectively, of our sales. One of these customers in 2005 and 2004 was a related party. During the nine months ended September 30, 2005 and 2004, four vendors accounted for 65% and 47%, respectively, of our purchases. Two of these vendors were related parties. Substantially all of our related party transactions are derived from our contract manufacturing division. If we were to lose one or more of these customers before we are able to secure sales from other customers, our income and financial condition would be adversely affected. If we are unable to enter into and maintain satisfactory distribution arrangements with leading suppliers and an adequate supply of products, our sales could be adversely affected.

 

There can be no assurance that we will complete our proposed acquisition of Astrophysics, but in the event we are able to do so, our shareholders will undergo significant equity dilution. On May 27, 2005, we entered into a non-binding letter of intent to acquire Astrophysics, Inc., a leading designer and manufacturer of X-ray scanning security systems. Pursuant to the letter of intent, we propose to acquire all of the assets, subject to all of the liabilities, of Astrophysics in exchange for $10 million of cash and issuance of our common shares in an amount equal to 50.1% of our issued and outstanding common shares after giving effect to the acquisition of Astrophysics and a proposed $25 million equity financing. Astrophysics will also receive, for no additional consideration, the right to receive additional common shares upon the exercise or conversion of our warrants, stock options and convertible securities that are outstanding as of the close of the transaction. The letter of intent requires us to raise $25 million of capital prior to the close of the Astrophysics acquisition, of which $10 million would be paid to Astrophysics, $10 million would be contributed to the business of Astrophysics, and the balance would be applied to our general working capital. The letter of intent originally contemplated that the parties would enter into a definitive agreement by June 30, 2005, which date was later extended to July 15, 2005. As of the date of this report, we have not entered into a definitive agreement to acquire Astrophysics. While we are continuing our discussions with Astrophysics, the parties have reached an impasse and there can be no assurance we will reach a definitive agreement concerning our proposed acquisition of Astrophysics. However, if we are successful in acquiring Astrophysics on the terms set forth in the letter of intent dated May 27, 2005, our shareholders will experience significant equity dilution due to the number of shares we will need to issue in connection with our acquisition of Astrophysics and the $25 million equity financing associated with the proposed transaction.

 

We are an emerging growth company with limited operating history. Following our acquisition of McDigit, Inc. in August 2003, and having essentially ceased operations of our prior businesses, we recommenced operations as a new business engaged in designing and selling industrial, business and consumer computers and computing solutions; and digital video, audio and data transmission and recording products. In 2004, we acquired substantial operating assets included in our digital technology division and aviation division. As a result, we have a limited history operating our current businesses and forecasting our sales. The future success of our business will depend on our ability to successfully operate our recently acquired businesses, all of which are in highly competitive markets. Moreover, our digital technology division operates in a new and emerging market. As a new company, it will be necessary for us to implement additional operational, financial and other controls and procedures in order to be successful.

 

Our digital technology business is new and based on emerging technologies. Market demand for digital technologies is uncertain. We have a limited history of marketing and selling our digital video products. We continue to assess internal and external feedback relating to these products but

 

6


Table of Contents

cannot guarantee that we will be able to successfully sell products based on those technologies. We initially focused on law enforcement and the military as potential markets for our digital video products and recently began to focus on other potential market segments, including industrial, commercial and homeland security. Demand for our digital video, audio and data transmission and recording products is uncertain as, among other reasons, our customers and potential customers may:

 

    not accept our emerging technologies or shift to other technologies;

 

    experience technical difficulty in installing or utilizing our products; or

 

    use alternative solutions to achieve their business objectives.

 

In addition, the lengthy and variable sales cycle for products sold by our digital technology division makes it difficult to predict sales and may result in fluctuations in quarterly operating results. Because customers often require a significant amount of time to evaluate products sold by our digital technology division before purchasing, the sales cycle associated with these products can be lengthy (exceeding one year in some cases). The sales cycles for these products also varies from customer to customer and are subject to a number of significant risks over which we have little or no control.

 

Government regulation of communications monitoring could cause a decline in the use of our digital video surveillance products, result in increased expenses, or subject us and our customers to regulation or liability. As the communications industry continues to evolve, governments may increasingly regulate products that monitor and record voice, video, and data transmissions over public communications networks. For example, the products we sell to law enforcement agencies, which interface with a variety of wireline, wireless, and Internet protocol networks must comply in the United States with the technical standards established by the Federal Communications Commission pursuant to the Communications Assistance for Law Enforcement Act and in Europe by the European Telecommunications Standard Institute. The adoption of new laws governing the use of our products or changes made to existing laws could cause a decline in the use of our products and could result in increased costs, particularly if we are required to modify or redesign products to accommodate these new or changing laws.

 

Our intellectual property rights may not be adequate to protect our business. We currently do not hold any patents for our products. To date, we have filed one patent application relating to certain elements of the technology underlying our digital video surveillance products. Although we expect to continue filing, where applicable, patent applications related to our technology, no assurances can be given that any patent will be issued on our patent application or any other application that we may file in the future or that, if such patents are issued, they will be sufficiently broad to adequately protect our technology. In addition, we cannot assure you that any patents that may be issued to us will not be challenged, invalidated, or circumvented.

 

Even if we are issued patents, they may not stop a competitor from illegally using our patented applications and materials. In such event, we would incur substantial costs and expenses, including lost time of management in addressing and litigating, if necessary, such matters. Additionally, we rely upon a combination of copyright, trademark and trade secret laws, license agreements and nondisclosure agreements with third parties and employees having access to confidential information or receiving unpatented proprietary know-how, trade secrets and technology to protect our proprietary rights and technology. These laws and agreements provide only limited protection. We can give no assurance that these measures will adequately protect us from misappropriation of proprietary information.

 

Our products may infringe on the intellectual property rights of others, which could lead to costly disputes or disruptions. The information technology industry is characterized by frequent

 

7


Table of Contents

allegations of intellectual property infringement. In the past, third parties have asserted that certain of our digital video surveillance products infringe on their intellectual property and they may do so in the future. Any allegation of infringement could be time consuming and expensive to defend or resolve, result in substantial diversion of management resources, cause product shipment delays or force us to enter into royalty, license, or other agreements rather than dispute the merits of such allegation. If patent holders or other holders of intellectual property initiate legal proceedings, we may be forced into protracted and costly litigation. We may not be successful in defending such litigation and may not be able to procure any required royalty or license agreements on acceptable terms or at all.

 

If our products infringe on the intellectual property rights of others, we may be required to indemnify customers for any damages they suffer. We generally indemnify our customers with respect to infringement by our products of the proprietary rights of third parties in the event any third party asserts infringement claims directly against our customers. These claims may require us to initiate or defend protracted and costly litigation on behalf of our customers, regardless of the merits of these claims. If any of these claims succeed, we may be forced to pay damages on behalf of our customers or may be required to obtain licenses for the products they use. If we cannot obtain all necessary licenses on commercially reasonable terms, our customers may be forced to stop using, or in the case of value added resellers, selling our products.

 

Our business strategy includes acquiring certain businesses and entering into joint ventures and strategic alliances. Failure to successfully integrate such businesses, joint ventures, or strategic alliances into our operations could adversely affect our business. In the past, we have acquired companies and assets and entered into certain strategic alliances, including the purchase of assets from Next Venture, Inc. and AirWorks, Inc. in April 2004. We are negotiating a proposed acquisition of Astrophysics and may make additional acquisitions and enter into joint ventures in the future. While we believe we will effectively integrate such businesses, joint ventures, or strategic alliances with our own, we may be unable to successfully do so and may be unable to realize expected cost savings and/or sales growth. Regarding the assets purchased from Next Venture and AirWorks, the acquired businesses are in emerging markets and their performance is subject to the inherent volatility of such markets. Furthermore, AirWorks’ assets were purchased from an assignee for the benefit of creditors, which means that the business was not successful in the past. Acquisitions, joint ventures and strategic alliances may involve significant other risks and uncertainties, including distraction of management’s attention away from normal business operations, insufficient revenue generation to offset liabilities assumed and expenses associated with the transaction, and unidentified issues not discovered in our due diligence process, such as product quality and technology issues and legal contingencies. In addition, in the case of acquisitions, we may be unable to effectively integrate the acquired companies’ marketing, technology, production, development, distribution and management systems. Our operating results could be adversely affected by any problems arising during or from acquisitions or from modifications or termination of joint ventures and strategic alliances or the inability to effectively integrate any future acquisitions.

 

8


Table of Contents

We may be obligated to issue more shares of common stock as a result of our recent acquisitions, and your ownership interest in Global ePoint may be diluted as a result. Pursuant to the reorganization and stock purchase agreement related to the acquisition of McDigit, we may be obligated to issue additional shares of our common stock to Mr. John Pan based on the achievement by us of specific financial milestones in 2005 and on the occurrence of other specific conditions. Accordingly, the final number of shares of our common stock that may be issued pursuant to this agreement may not be known until sometime in 2006; provided, that we know that the aggregate number of shares of common stock that may be issued pursuant to the agreement will not exceed 85% of the then issued and outstanding shares of our common stock. In addition, we may be required to assume more debt or issue common stock to support our purchases of assets from Next Venture and AirWorks’ assignee.

 

USE OF PROCEEDS

 

We will not receive any of the proceeds from sales of common stock by any selling stockholder. We will receive gross proceeds of up to $15,569,316 from the exercise of the warrants to purchase 3,008,183 shares of common stock if and when the warrants held by the selling stockholders are exercised. We intend to use the net proceeds, if any, from the exercise of the warrants for our general working capital needs. There can be no assurance that the warrants will be exercised.

 

9


Table of Contents

SELLING STOCKHOLDERS

 

This prospectus relates to the offering and sale, from time to time, of up to 4,450,494 shares of our common stock issuable upon conversion of Series D Preferred Stock and the exercise of warrants held by the stockholders named in the table below. The selling stockholders may convert their shares of Series D Preferred Stock into shares of common stock and exercise their warrants at any time in their sole discretion. All of the selling stockholders named below acquired their shares of our Series D Preferred Stock and warrants directly from us in private transactions.

 

On November 7, 2005, we issued to the selling stockholders an aggregate of 120,000 shares of our Series D Preferred Stock at a price of $50.00 per share for aggregate initial gross proceeds of $6.0 million. The Series D Preferred Stock is initially convertible into shares of common stock at rate of $4.16 per common share. We also granted to the selling stockholders warrants to purchase common shares as follows: an aggregate of 721,157 shares over a three year period at an exercise price of $4.33 per share; an aggregate of 1,442,311 shares for a period of ninety (90) business days following the effective date of this registration statement at an exercise price of $5.25 per share; and, solely in connection with the exercise of the second group of warrants, an aggregate of 721,157 shares over a three year period at an exercise price of $6.00 per share. These securities were offered and sold in reliance upon exemptions from registration pursuant to Section 4(2) under the Securities Act of 1933, as amended, and Rule 506 thereunder.

 

In connection with the Series D financing and previous financing transactions, we issued to H.C. Wainwright & Co. warrants to purchase shares of our common stock as follows: on December 22, 2004, warrants to purchase an aggregate of 25,000 shares over a three year period at an exercise price of $6.91 per share; on June 2, 2005, warrants to purchase an aggregate of 62,500 shares over a three year period at an exercise price of $3.50 per share; and on November 7, 2005, warrants to purchase an aggregate of 36,058 shares over a three year period at an exercise price of $4.33 per share. The warrants were issued to H.C. Wainwright, an NASD member firm, as compensation for its services as placement agent in connection with the financing transactions. H.C. Wainwright is purchasing the securities being registered hereunder in the ordinary course of business, and has no agreements or understandings, directly or indirectly, with any person to distribute the securities.

 

The following table sets forth certain information known to us as of November 30, 2005 and as adjusted to reflect the sale of the shares offered hereby, with respect to the beneficial ownership of the Company’s common stock by the selling stockholders. The table assumes the conversion of all shares of the Company’s convertible preferred stock outstanding as of November 30, 2005. The share amounts under the column, “Number of shares being offered” consist of the shares of our common stock underlying the Series D Preferred Stock, the warrants issued in connection with the Series D financing described above, and the warrants issued to H.C. Wainwright. The share amounts under the column, “Shares beneficially owned before the offering” also include securities held by the selling stockholders in addition to the shares relating to the Series D financing.

 

The selling stockholders may sell all or some of the shares of common stock they are offering, and may sell shares of our common stock otherwise than pursuant to this prospectus. The table below assumes that each selling stockholder exercises all of its warrants and sells all of the shares issued upon exercise thereof, and that each selling stockholder sells all of the shares offered by it in offerings pursuant to this prospectus, and does not acquire any additional shares. We are unable to determine the exact number of shares that will actually be sold or when or if these sales will occur.

 

     Shares beneficially
owned before
the offering


   

Number of

shares being
offered


  

Shares beneficially

owned after offering


 

Name of beneficial owner


   Number

    Percentage

       Number

   Percentage

 

Iroquois Master Fund Ltd.

   3,452,615 (1)   17.8 %   2,992,792    459,823    2.6 %

Omicron Master Trust

   699,797 (2)   4.0 %   540,868    158,929    *  

Smithfield Fiduciary LLC

   628,438 (3)   3.6 %   360,580    267,858    1.6 %

Nite Capital LP

   382,077 (4)   2.2 %   216,348    165,729    *  

The Tail Wind

Fund, Ltd.

   377,063 (5)   2.2 %   216,348    160,715    *  

H.C. Wainwright & Co. 

   123,558     *     123,558    0    0 %

* Less than 1%

 

10


Table of Contents
(1) Includes the following securities relating to the Series D financing: 997,597 shares underlying the Series D Preferred Stock, 498,799 shares issuable upon the exercise of warrants at an exercise price of $4.33 per share, 997,597 shares issuable upon the exercise of warrants at an exercise price of $5.25 per share, and 498,799 shares issuable upon the exercise of warrants at an exercise price of $6.00 per share. In addition, includes 459,823 shares beneficially held by Iroquois Capital, LP. Joshua Silverman has voting and investment control over the securities held by Iroquois Capital, LP and Iroquois Master Fund Ltd. Mr. Silverman disclaims beneficial ownership of the shares held by Iroquois Capital, LP and Iroquois Master Fund Ltd.

 

(2) Includes the following securities relating to the Series D financing: 180,289 shares underlying the Series D Preferred Stock, 90,145 shares issuable upon the exercise of warrants at an exercise price of $4.33 per share, 180,289 shares issuable upon the exercise of warrants at an exercise price of $5.25 per share, and 90,145 shares issuable upon the exercise of warrants at an exercise price of $6.00 per share. Also includes 44,643 shares issuable upon the exercise of warrants at an exercise price of $3.50 per share and 25,000 shares issuable upon the exercise of warrants at an exercise price of $6.91 per share, relating to prior financings. Omicron Capital, L.P., a Delaware limited partnership (“Omicron Capital”), serves as investment management to Omicron Master Trust, a trust formed under the laws of Bermuda (“Omicron”); Omicron Capital, Inc., a Delaware corporation, (“OCI”), serves as general partner of Omicron Capital, and Winchester Global Trust Company Limited (“Winchester”) serves as the trustee of Omicron. By reason of such relationships, Omicron Capital and OCI may be deemed to share dispositive power over the shares of our common stock owned by Omicron, and Winchester may be deemed to share voting and dispositive power over the shares of our common stock owned by Omicron. Omicron Capital, OCI and Winchester disclaim beneficial ownership of such shares of our common stock. Omicron Capital has delegated authority from the board of directors of Winchester regarding the portfolio management decisions with respect to the shares of common stock owned by Omicron, and, as of November 16, 2005, Mr. Olivier H. Morali and Mr. Bruce T. Bernstein, officers of OCI, have delegated authority from the board of directors of OCI regarding the portfolio management decisions of Omicron Capital with respect to the shares of common stock owned by Omicron. By reason of such delegated authority, Messrs. Morali and Bernstein may be deemed to share dispositive power over the shares of our common stock owned by Omicron. Messrs. Morali and Bernstein disclaim beneficial ownership of such shares of our common stock and neither of such persons has any legal right to maintain such delegated authority. No other person has sole or shared voting or dispositive power with respect to the shares of our common stock being offered by Omicron, as those terms are used for purposes under Regulation 13D-G of the Securities Exchange Act of 1934, as amended. Omicron and Winchester are not “affiliates” of one another, as that term is used for purposes of the Securities Exchange Act of 1934, as amended, or of any other person named in this prospectus as a selling stockholder. No person, or “group” (as that term is used in Section 13(d) of the Securities Exchange Act of 1934, as amended, or the SEC’s Regulation, 13D-G) controls Omicron and Winchester.

 

(3) Includes the following securities relating to the Series D financing: 120,193 shares underlying the Series D Preferred Stock, 60,097 shares issuable upon the exercise of warrants at an exercise price of $4.33 per share, 120,193 shares issuable upon the exercise of warrants at an exercise price of $5.25 per share, and 60,097 shares issuable upon the exercise of warrants at an exercise price of $6.00 per share. Also includes 89,286 shares issuable upon the exercise of warrants at an exercise price of $3.50 per share relating to a prior financing. Highbridge Capital Management, LLC is the trading manager of Smithfield Fiduciary LLC and has voting control and investment discretion over securities held by Smithfield Fiduciary LLC. Glen Dubin and Henry Swieca control Highbridge Capital Management, LLC. Each of Highbridge Capital Management, LLC, Glen Dubin and Henry Swieca disclaims beneficial ownership of the securities held by Smithfield Fiduciary LLC.

 

(4)

Includes the following securities relating to the Series D financing: 72,116 shares underlying the Series D Preferred Stock, 36,058 shares issuable upon the exercise of warrants at an exercise price of $4.33 per share, 72,116 shares issuable upon the exercise of warrants at an exercise price of $5.25 per share, and 36,058 shares issuable upon the exercise of warrants at an exercise price of $6.00 per share. Also includes 44,643 shares issuable upon the exercise of warrants at an exercise price of $3.50 per share relating to a prior financing. Keith Goodman, Manager of the General Partner of Nite Capital, LP has voting control

 

11


Table of Contents

and investment discretion over securities held by Nite Capital, LP. Mr. Goodman disclaims beneficial ownership of the shares held by Nite Capital, LP.

 

(5) Includes the following securities relating to the Series D financing: 72,116 shares underlying the Series D Preferred Stock, 36,058 shares issuable upon the exercise of warrants at an exercise price of $4.33 per share, 72,116 shares issuable upon the exercise of warrants at an exercise price of $5.25 per share, and 36,058 shares issuable upon the exercise of warrants at an exercise price of $6.00 per share. Also includes 53,572 shares issuable upon the exercise of warrants at an exercise price of $3.50 per share relating to a prior financing. Tail Wind Advisory & Management Ltd., a UK corporation authorized and regulated by the Financial Services Authority of Great Britain (“TWAM”) is the investment manager for The Tail Wind Fund Ltd., and David Crook is the Chief Executive Officer and controlling shareholder of TWAM. Each of TWAM and David Crook expressly disclaims any equitable or beneficial ownership of the shares being registered hereunder and held by The Tail Wind Fund Ltd.

 

Except as otherwise indicated above or in the footnotes to the table, the selling stockholders have not held any position or office or had any material relationship with our company or any of its subsidiaries within the past three years and the selling stockholders possess sole voting and investment power with respect to the shares shown. No selling stockholder is a broker-dealer, or an affiliate of a broker-dealer.

 

12


Table of Contents

PLAN OF DISTRIBUTION

 

The selling stockholders may, from time to time, sell any or all of their shares of common stock on any stock exchange, market or trading facility on which the shares are traded or in private transactions. These sales may be at fixed or negotiated prices. The selling stockholders may use any one or more of the following methods when selling shares:

 

    ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers;

 

    block trades in which the broker-dealer will attempt to sell the shares as agent but may position and resell a portion of the block as principal to facilitate the transaction;

 

    purchases by a broker-dealer as principal and resale by the broker-dealer for its account;

 

    an exchange distribution in accordance with the rules of the applicable exchange;

 

    privately negotiated transactions;

 

    short sales;

 

    broker-dealers may agree with the selling stockholders to sell a specified number of such shares at a stipulated price per share;

 

    a combination of any such methods of sale; and

 

    any other method permitted pursuant to applicable law.

 

The selling stockholders may also sell shares under Rule 144 under the Securities Act, if available, rather than under this prospectus.

 

The selling stockholders may also engage in puts and calls and other transactions in our securities or derivatives of our securities and may sell or deliver shares in connection with these trades.

 

Broker-dealers engaged by the selling stockholders may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive commissions or discounts from the selling stockholders (or, if any broker-dealer acts as agent for the purchaser of shares, from the purchaser) in amounts to be negotiated. The selling stockholders do not expect these commissions and discounts to exceed what is customary in the types of transactions involved. Any profits on the resale of shares of common stock by a broker-dealer acting as principal might be deemed to be underwriting discounts or commissions under the Securities Act. Discounts, concessions, commissions and similar selling expenses, if any, attributable to the sale of shares will be borne by a selling stockholder. The selling stockholders may agree to indemnify any agent, dealer or broker-dealer that participates in transactions involving sales of the shares if liabilities are imposed on that person under the Securities Act.

 

The selling stockholders may from time to time pledge or grant a security interest in some or all of the shares of common stock owned by them and, if they default in the performance of their secured obligations, the pledgees or secured parties may offer and sell the shares of common stock from time to time under this prospectus after we have filed a supplement to this prospectus under Rule 424(b)(3) or other applicable provision of the Securities Act of 1933 amending the list of selling stockholders to include the pledgee, transferee or other successors in interest as selling stockholders under this prospectus.

 

13


Table of Contents

The selling stockholders also may transfer the shares of common stock in other circumstances, in which case the transferees, pledgees or other successors in interest will be the selling beneficial owners for purposes of this prospectus and may sell the shares of common stock from time to time under this prospectus after we have filed a supplement to this prospectus under Rule 424(b)(3) or other applicable provision of the Securities Act of 1933 amending the list of selling stockholders to include the pledgee, transferee or other successors in interest as selling stockholders under this prospectus.

 

The selling stockholders and any broker-dealers or agents that are involved in selling the shares of common stock may be deemed to be “underwriters” within the meaning of the Securities Act in connection with such sales. In such event, any commissions received by such broker-dealers or agents and any profit on the resale of the shares of common stock purchased by them may be deemed to be underwriting commissions or discounts under the Securities Act.

 

We are required to pay all fees and expenses incident to the registration of the shares of common stock. We have agreed to indemnify the selling stockholders against certain claims, damages and liabilities, including liabilities under the Securities Act.

 

The selling stockholders have advised us that they have not entered into any agreements, understandings or arrangements with any underwriters or broker-dealers regarding the sale of their shares of common stock, nor is there an underwriter or coordinating broker acting in connection with a proposed sale of shares of common stock by any selling stockholder. If we are notified by any selling stockholder that any material arrangement has been entered into with a broker-dealer for the sale of shares of common stock, if required, we will file a supplement to this prospectus. If the selling stockholders use this prospectus for any sale of the shares of common stock, they will be subject to the prospectus delivery requirements of the Securities Act.

 

The anti-manipulation rules of Regulation M under the Securities Exchange Act of 1934 may apply to sales of our common stock and activities of the selling stockholders.

 

14


Table of Contents

DESCRIPTION OF SECURITIES TO BE REGISTERED

 

Common Stock

 

We are authorized to issue 50,000,000 shares of common stock, of which, as of November 30, 2005, 14,785,210 shares were issued and outstanding and held by approximately 453 record holders. Holders of shares of common stock are entitled to one vote per share on all matters to be voted upon by the stockholders generally. The approval of proposals submitted to stockholders at a meeting other than for the election of directors requires the favorable vote of a majority of the shares voting, except in the case of certain fundamental matters (such as certain amendments to the certificate of incorporation, and certain mergers and reorganizations), in which cases Nevada law and our bylaws require the favorable vote of at least a majority of all outstanding shares. Stockholders are entitled to receive such dividends as may be declared from time to time by the board of directors out of funds legally available therefore, and in the event of liquidation, dissolution or winding up, to share ratably in all assets remaining after payment of liabilities. The holders of shares of common stock have no preemptive, conversion, subscription or cumulative voting rights.

 

Undesignated Preferred Stock

 

We are authorized to issue 2,000,000 shares of preferred stock, of which 55,000 shares have been designated “Series A Preferred Stock”, all of which are issued and none of which are currently outstanding; 55,000 have been designated “Series B Preferred Stock”, 15,000 of which are issued and none of which are outstanding; 1,250,010 have been designated “Series C Preferred Stock”, 1,250,004 of which have been issued, and 1,000,718 of which are currently outstanding; and 200,000 have been designated “Series D Preferred Stock”, 120,000 of which are currently issued and outstanding (as described below). Our board of directors is authorized to issue from time to time, without stockholder authorization, in one or more designated series or classes, any or all of the authorized but unissued shares of preferred stock with such dividend, redemption, conversion and exchange provisions as may be provided in the particular series. Any series of preferred stock may possess voting, dividend, liquidation and redemption rights superior to that of the common stock. The rights of the holders of common stock will be subject to and may be adversely affected by the rights of the holders of any preferred stock that may be issued in the future. Issuance of a new series of preferred stock, while providing desirable flexibility in connection with possible acquisition and other corporate purposes, could make it more difficult for a third party to acquire, or discourage a third party from acquiring, a majority of the outstanding voting stock of the Company.

 

Series A Preferred Stock

 

We previously issued 55,000 shares of Series A Preferred Stock, all of which have been converted into shares of our common stock.

 

Series B Preferred Stock

 

We previously issued 15,000 shares of Series B Preferred Stock, all of which have been converted into shares of our common stock.

 

Series C Preferred Stock

 

We previously issued 1,250,004 shares of Series C Preferred Stock, 1,000,718 of which are currently outstanding. The balance have been converted into shares of our common stock. The Series C Preferred Stock, including all accrued and unpaid dividends, is convertible into shares of common stock

 

15


Table of Contents

at the rate of $2.80 per common share, based on a value of $2.80 for each share of Series C Preferred Stock. The conversion price is not subject to adjustment, except for standard anti-dilution adjustments relating to stock splits, combinations and the like. Upon a liquidation, dissolution or winding up of Global ePoint, the holders of Series C Preferred Stock are entitled to be paid first out of the assets of the Company available for distribution to the stockholders an amount equal to $2.80 per share of Series C Preferred Stock. Except as required by law, the holders of Series C Preferred Stock have no voting rights.

 

Series D Preferred Stock

 

There are 120,000 shares of Series D Preferred Stock currently issued and outstanding. The Series D Preferred Stock, including all accrued and unpaid dividends, is convertible into shares of common stock at the rate of $4.16 per common share, based on a value of $50.00 for each share of Series D Preferred Stock. The conversion price is not subject to adjustment, except for standard anti-dilution adjustments relating to stock splits, combinations and the like. We must redeem 75% of the principal value of the Series D Preferred Stock in seven equal payments beginning in August 2006, and every third month thereafter. The redemption price is equal to the purchase price of the shares being redeemed, plus all related accrued and unpaid dividends. The balance of the Series D Preferred Stock is subject to redemption on or before November 7, 2010. Upon a liquidation, dissolution or winding up of Global ePoint, the holders of Series D Preferred Stock are entitled to be paid out of the assets of the Company available for distribution to the stockholders, ahead of all shareholders except the holders of the Series C Preferred Stock, an amount equal to $50.00 per share of Series D Preferred Stock. Except as required by law, the holders of Series D Preferred Stock have no voting rights.

 

Rights of First Refusal; Right to Exchange Shares

 

Pursuant to the terms of a Securities Purchase Agreement, dated December 19, 2004, by and among the Company and certain institutional investors (the “Investors”), the Investors have a limited right of first refusal to participate in all equity offerings of the Company on a pro rata basis up to (i) the first $2,500,000 worth of securities being offered, if the placement is made or offered to a bank or NASD member firm, or (ii) 50% of the total offering if the placement is made or offered to any other entity. If any Investor declines to participate in an offering, the participating Investors may collectively purchase additional securities in the offering up to the maximum number of securities subject to the right of first refusal. The Investors’ right of first refusal terminates on December 22, 2005.

 

Pursuant to the terms of a Securities Purchase Agreement, dated November June 2, 2005, by and among the Company and the holders of the Series C Preferred Stock (the “Series C Holders”), if the Company offers to issue or issues to any person or entity any securities of the Company (the “Offered Securities”), the Series C Holders have the right to exchange all or any portion of their shares of Series C Preferred Stock for the Offered Securities. This right terminates once the Company has consummated one or more equity financings resulting in gross proceeds to the Company in excess of $24 million, in the aggregate, following the closing of the Series C financing.

 

Pursuant to the terms of a Securities Purchase Agreement, dated November 7, 2005, by and among the Company and the holders of the Series D Preferred Stock (the “Series D Holders”), the Series D Holders have a limited right of first refusal to participate in all equity offerings of the Company on a pro rata basis up to 50% of the total offering. If any Series D Holder declines to participate in an offering, the participating Series D Holders may collectively purchase additional securities in the offering up to the maximum number of securities subject to the right of first refusal. The Series D Holders’ right of first refusal terminates 90 business days after the date of this registration statement. In addition, if the Company offers to issue, or issues any Offered Securities to any person or entity, the Series D Holders have the right to exchange all or any portion of their shares of Series D Preferred Stock for the Offered

 

16


Table of Contents

Securities. This right terminates once the Company has consummated one or more equity financings resulting in gross proceeds to the Company in excess of $15 million, in the aggregate, following the closing of the Series D financing.

 

LEGAL MATTERS

 

The validity of the shares of common stock offered hereby will be passed upon by Preston Gates & Ellis LLP, Irvine, California.

 

EXPERTS

 

Our financial statements incorporated in this prospectus by reference to our Annual Report on Form 10-KSB for the fiscal years ended December 31, 2004 and 2003 have been audited by Haskell & White LLP, an independent registered public accounting firm. These financial statements have been incorporated in this prospectus by reference in reliance upon the report of Haskell & White LLP, pertaining to such financial statements and upon the authority of such firm as experts in auditing and accounting.

 

AVAILABLE INFORMATION

 

We file annual, quarterly, and current reports, proxy statements, and other documents with the SEC. You may read and copy any document we file at the SEC’s public reference room at Judiciary Plaza Building, 450 Fifth Street, N.W., Room 1024, Washington, D.C. 20549. You should call 1-800-SEC-0330 for more information on the public reference room. The SEC maintains an internet site at http://www.sec.gov where certain reports, proxy and information statements, and other information regarding issuers (including Global ePoint) may be found. In addition, such material concerning the Company may be inspected at the offices of the NASDAQ stock market.

 

This prospectus is part of a registration statement filed with the SEC. The registration statement contains more information than this prospectus regarding our company and its common stock, including certain exhibits filed. You can get a copy of the registration statement from the SEC at the address listed above or from the SEC’s internet site.

 

INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE

 

The SEC allows us to “incorporate” into this prospectus information we file with it in other documents. This means that we can disclose important information to you by referring to other documents that contain that information. The information incorporated by reference is considered to be part of this prospectus, and information we file later with the SEC will automatically update and supersede this information. We incorporate by reference the documents listed below, except to the extent information in those documents is different from the information contained in this prospectus, and all future documents filed with the SEC under Sections 13(a), 13(c), 14, or 15(d) of the Securities Exchange Act of 1934 until we terminate the offering of these shares.

 

    Quarterly Report on Form 10-QSB for the quarterly period ended September 30, 2005, filed on November 14, 2005.

 

    Current Report on Form 8-K filed on November 14, 2005.

 

17


Table of Contents
    Current Report on Form 8-K/A filed on October 12, 2005.

 

    Quarterly Report on Form 10-QSB/A for the quarterly period ended March 31, 2005, filed on October 12, 2005.

 

    Current Report on Form 8-K filed on September 29, 2005.

 

    Current Report on Form 8-K filed on August 26, 2005.

 

    Quarterly Report on Form 10-QSB for the quarterly period ended June 30, 2005, filed on August 19, 2005.

 

    Current Report on Form 8-K filed on June 14, 2005.

 

    Definitive Proxy Statement filed on June 14, 2005.

 

    Current Report on Form 8-K filed on June 9, 2005.

 

    Current Report on Form 8-K filed on June 3 2005.

 

    Definitive Proxy Statement filed on June 3, 2005.

 

    Current Report on Form 8-K filed on May 26, 2005.

 

    Quarterly Report on Form 10-QSB for the quarterly period ended March 31, 2005, filed on May 23, 2005.

 

    Current Report on Form 8-K/A filed on May 9, 2005.

 

    Current Report on Form 8-K filed on May 6, 2005.

 

    Annual Report on Form 10-KSB filed on April 15, 2005 for the year ended December 31, 2004.

 

We will provide without charge to each person, including any beneficial owner of common stock, to whom this prospectus is delivered, upon the written or oral request of such person, a copy of any and all of the documents that have been incorporated by reference in this prospectus (not including exhibits to such documents unless such exhibits are specifically incorporated by reference therein). Requests should be directed to: Global ePoint, Inc., 339 South Cheryl Lane, City of Industry, California 91789, Attention: Toresa Lou, Chief Executive Officer, Telephone: (909) 869-1688.

 

18


Table of Contents

PART II

INFORMATION NOT REQUIRED

IN PROSPECTUS

 

Item 14. Itemized Statement of Expenses.

 

The table below sets forth the estimated expenses (except the SEC registration fee, which is an actual expense) in connection with the offer and sale of the shares of common stock of the registrant covered by this Registration Statement.

 

SEC Registration Fee

   $ 1,370

Legal Fees and Expenses

   $ 25,000

Accounting Fees and Expenses

   $ 5,000

Printing Fees and Expenses

   $ 2,500

Miscellaneous

   $ 1,500
    

Total

   $ 35,370

 

Item 15. Indemnification of Directors and Officers.

 

Nevada law and Global ePoint’s articles of incorporation and bylaws provide that Global ePoint shall, under certain circumstances and subject to certain limitations, indemnify any director, officer, employee or agent of the corporation made or threatened to be made a party to a proceeding, by reason of the former or present official capacity of the person, against judgments, fines, settlements and reasonable expenses incurred by the person in connection with the proceeding if certain statutory standards are met. Any such person is also entitled, subject to certain limitations, to payment or reimbursement of reasonable expenses in advance of the final disposition of the proceeding. “Proceeding” means a threatened, pending or completed civil, criminal, administrative, arbitration or investigative proceeding, including one by or in the right of the corporation.

 

Item 16. Exhibits.

 

The exhibits to this registration statement are listed in the Index to Exhibits on Page II-5.

 

Item 17. Undertakings.

 

(a) The undersigned Registrant hereby undertakes:

 

  (1) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:

 

  (i) To include any prospectus required by Section 10(a)(3) of the Securities Act of 1933;

 

  (ii)

To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20% change in the

 

II-1


Table of Contents

maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective registration statement;

 

  (iii) To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement;

 

provided, however, that paragraphs (a)(1)(i), (a)(1)(ii) and (a)(1)(iii) of this section do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in periodic reports filed by registrant pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the registration statement.

 

  (2) That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

 

  (3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

 

  (4) That, for the purpose of determining liability under the Securities Act of 1933 to any purchaser, each prospectus filed pursuant to Rule 424(b) as part of a registration statement relating to an offering shall be deemed to be part of and included in the registration statement as of the date it is first used after effectiveness, provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, modify or supersede any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such date of first use.

 

(b) The undersigned registrant hereby undertakes that, for the purposes of determining any liability under the Securities Act of 1933, each filing of the registrant’s annual report pursuant to Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to Section 15(d) of the Securities Exchange Act of 1934) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

 

(c) Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the provisions described under Item 15 above, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act of 1933 and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act of 1933 and will be governed by the final adjudication of such issue.

 

II-2


Table of Contents

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this pre-effective amendment no. 1 to registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Industry, State of California on December 2, 2005.

 

GLOBAL EPOINT, INC.

By:   /s/    TORESA LOU        
   

Toresa Lou,

Chief Executive Officer

 

Pursuant to the requirements of the Securities Act of 1933, this pre-effective amendment no. 1 to registration statement has been signed by the following persons in the capacities on December 2, 2005.

 

Signature


  

Title


/s/    John Pan      


John Pan

  

Chairman of the Board and Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)

/s/    Toresa Lou        


Toresa Lou

  

Chief Executive Officer and Director (Principal Executive Officer)


John Yuan

  

Director

*


William W. Dolph, M.D.

  

Director


Jongil Kim

  

Director


Owen Lee Barnett

  

Director

*


Daryl F. Gates

  

Director


Lawrence S. Leong

  

Director

*


James D. Smith

  

Director

*By:   /S/    TORESA LOU        
    Toresa Lou, Attorney-in-Fact

 

II-3


Table of Contents

INDEX TO EXHIBITS

 

Exhibit

     
2.1     Securities Purchase Agreement (Incorporated by reference to Exhibit 10.1 to Form 8-K filed on November 14, 2005)
4.1     Certificate of Designations of Rights and Preferences of Series D Convertible Preferred Stock (Incorporated by reference to Exhibit 3i.3 to Form 8-K filed on November 14, 2005)
4.2     Registration Rights Agreement (Incorporated by reference to Exhibit 10.2 to Form 8-K filed on November 14, 2005)
4.3     Form of Warrant A (Incorporated by reference to Exhibit 10.3 to Form 8-K filed on November 14, 2005)
4.4     Form of Warrant B (Incorporated by reference to Exhibit 10.4 to Form 8-K filed on November 14, 2005)
4.5     Form of Warrant C (Incorporated by reference to Exhibit 10.5 to Form 8-K filed on November 14, 2005)
5.1 **   Opinion and Consent of Preston Gates & Ellis LLP
23.1 **   Consent of Preston Gates & Ellis LLP (included in Exhibit 5.1)
23.2 *   Consent of Haskell & White LLP
24.1 **   Power of Attorney (included on Page II-3 of this Registration Statement)

  * Filed herewith.
** Previously filed.

 

II-4